Solasia Pharma K. K. is a specialty pharmaceutical company established to develop and commercialize innovative oncology therapies and cancer supportive care products in Japan and other Asian countries.
～Provide Better Medicines to Patients for Brighter Future～
Mission: To provide access to Better Medicines for a Brighter Tomorrow
To accomplish this mission, our business strategy starts with in-licensing new promising pharmaceutical compounds from Japanese and western pharmaceutical/biotech companies.
In addition to conducting Pan Asian trials to obtain approval in Japan, China and other Asian countries, we expedite development and registration of our in-licensed programs by leveraging western clinical data.
“Sol” means the “Sun” in Spanish and so our company name “Solasia” stands for “the Sun in Asia”. We are committed to building and running Solasia’s business with drive and passion, as “the Sun in Asia”, to provide improved treatment options helpful to all cancer patients and healthcare providers.
President & Representative Director
Solasia Pharma K. K.